EQ Equillium
- 1.5000
- +0.0300+2.04%
- 1.5000
- 0.00000.00%
Equillium News
Equillium | 4: Statement of changes in beneficial ownership of securities-Director DEMSKI MARTHA J
Equillium | 4: Statement of changes in beneficial ownership of securities-Director Pruzanski Mark
Equillium | 4: Statement of changes in beneficial ownership of securities-Director MANIAN BALA S
Equillium | 4: Statement of changes in beneficial ownership of securities-Director McDermott Charles Douglas
Equillium | 4: Statement of changes in beneficial ownership of securities-Director Xu Yu (Katherine)
Equillium | 4: Statement of changes in beneficial ownership of securities-Director Troupin Barbara
Equillium | 3: Initial statement of beneficial ownership of securities-Officer Tom Penny
Equillium | SC 13G: Statement of acquisition of beneficial ownership by individuals-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)
Equillium | 4: Statement of changes in beneficial ownership of securities-Officer BRADBURY DANIEL
Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Steel Bruce D.
Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Connelly Stephen
Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Rothman Joel
Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Keyes Jason A
Equillium | 4: Statement of changes in beneficial ownership of securities-Officer Zedelmayer Christine
Equillium | 4: Statement of changes in beneficial ownership of securities-Director Xu Yu (Katherine)
Equillium | 4: Statement of changes in beneficial ownership of securities-Director Troupin Barbara
Equillium | 4: Statement of changes in beneficial ownership of securities-Director Pruzanski Mark
Equillium | 4: Statement of changes in beneficial ownership of securities-Director McDermott Charles Douglas
Equillium | 4: Statement of changes in beneficial ownership of securities-Director MANIAN BALA S
Equillium | 4: Statement of changes in beneficial ownership of securities-Director DEMSKI MARTHA J
Analysis
Price Target
No Data
